About Diagnósticos Rápidos

Diagnósticos Rápidos España (DRE) is the exclusive representative for Spain of the North American companies America Bio Medica Corporation and GlobaleMed Corporation. The former manufactures and markets rapid diagnostic tests for the detection of drugs and alcohol, both in urine and saliva, while GlobaleMed distributes worldwide one-step rapid diagnostic samples for the detection of gastric diseases, infectious diseases, tumor markers, cardiac markers, pregnancy and fertility tests, etc.

Due to the characteristics and advantages of our products, we hope to satisfy the needs of your institution and/or company and become your best ally in the clinical diagnostic area.

Note: This article has been translated using a computer system without human intervention. LUMITOS offers these automatic translations to present a wider range of company presentation. Since this article has been translated with automatic translation, it is possible that it contains errors in vocabulary, syntax or grammar. The original article in Spanish can be found here.

Facts about Diagnósticos Rápidos
  • Focus : Distributor
  • Industry : Diagnostics

Product portfolio of Diagnósticos Rápidos

Product portfolio

Here you will find Diagnósticos Rápidos de España, S.L.

See the theme worlds for related content

Topic world Diagnostics

Diagnostics is at the heart of modern medicine and forms a crucial interface between research and patient care in the biotech and pharmaceutical industries. It not only enables early detection and monitoring of disease, but also plays a central role in individualized medicine by enabling targeted therapies based on an individual's genetic and molecular signature.

10+ products
4 whitepaper
10+ brochures
View topic world

Topic world Diagnostics

Diagnostics is at the heart of modern medicine and forms a crucial interface between research and patient care in the biotech and pharmaceutical industries. It not only enables early detection and monitoring of disease, but also plays a central role in individualized medicine by enabling targeted therapies based on an individual's genetic and molecular signature.

10+ products
4 whitepaper
10+ brochures